Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.

Blood - 18 Apr 2013

Dreger Peter, Schnaiter Andrea, Zenz Thorsten, Böttcher Sebastian, Rossi Marianna, Paschka Peter, Bühler Andreas, Dietrich Sascha, Busch Raymonde, Ritgen Matthias, Bunjes Donald, Zeis Matthias, Stadler Michael, Uharek Lutz, Scheid Christof, Hegenbart Ute, Hallek Michael, Kneba Michael, Schmitz Norbert, Döhner Hartmut, Stilgenbauer Stephan

Abstract excerpt

The purpose of this analysis was to provide 6-year follow-up of the CLL3X trial, which studied reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT) in patients with poor-risk chronic lymphocytic leukemia (CLL), and to investigate the effect of TP53, SF3B1, and NOTCH1 mutati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Phosphoproteins

Share to Receptor, Notch1

Share to Ribonucleoprotein, U2 Small Nuclear

Share to RNA Splicing Factors

Share to Transplantation, Homologous

Source

Identifiers

PMID: 23435461
DOI: 10.1182/blood-2012-11-469627

Genes

NOTCH1
EFS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23435461-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.PMID 23435461Read ↗

Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20‐year cohortSemantic proximity Read ↗

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaSemantic proximity Read ↗

New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective.Semantic proximity Read ↗

Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 TrialSemantic proximity Read ↗

Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?Semantic proximity Read ↗

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53.Semantic proximity Read ↗

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialSemantic proximity Read ↗

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.Semantic proximity Read ↗

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.Semantic proximity Read ↗

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.Semantic proximity Read ↗

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.